Literature DB >> 2853905

Exfoliation syndrome among Saudis.

P Summanen1, A M Tönjum.   

Abstract

The prevalence of exfoliation syndrome among Saudis was determined during the National Survey of Blindness and Eye Disease in 1984 in Kingdom of Saudi Arabia. The subsample of this study consists of 376 persons aged 40 years or more from 50 different locations examined under mydriasis by the authors using Kowa hand-held microscope. There were 192 men and 184 women with the mean age of 56.0 +/- 1.2 years (median 53.5 years, range 40-95 years). The overall prevalence of exfoliation syndrome was 9.3%: in the age group 40 to 49 years 1.6%, 50 to 59 years 7.8%, 60 to 69 years 8.9%, and 26.5% in persons 70 years of age and over. No significant association was found between exfoliation syndrome and sex or parental kinship. In 16 persons the exfoliation syndrome was unilateral, and in 19 persons bilateral. In 24 eyes the phenomenon could not be evaluated due to the anterior segment pathology. Exfoliation syndrome was associated with higher intraocular pressure (20 +/- 3 mmHg (n = 49) vs. 17 +/- 0.4 mmHg (n = 601), P less than 0.05), and more cataract changes (P less than 0.001) than eyes without. These eyes were also associated with poorer visual acuity than the eyes without exfoliation syndrome: in 26 of 35 persons with exfoliation syndrome, the affected eye was the better eye but in 35% the vision was less than 0.05 (less than 3/60) i.e. the person was blind, compared to 6% of persons whose better eye did not have exfoliation syndrome (P less than 0.001).

Entities:  

Mesh:

Year:  1988        PMID: 2853905     DOI: 10.1111/j.1755-3768.1988.tb02639.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Suppl


  16 in total

1.  Prevalence of pseudoexfoliation syndrome and its association with ocular and systemic diseases in Eskisehir, Turkey.

Authors:  Nilgun Yildirim; Erdogan Yasar; Huseyin Gursoy; Ertugrul Colak
Journal:  Int J Ophthalmol       Date:  2017-01-18       Impact factor: 1.779

Review 2.  The medical and surgical management of pseudoexfoliation glaucoma.

Authors:  Manishi A Desai; Richard K Lee
Journal:  Int Ophthalmol Clin       Date:  2008

3.  Glaucoma, challenges and opportunities.

Authors:  Jose Morales
Journal:  Saudi J Ophthalmol       Date:  2011-09-16

Review 4.  Exfoliation syndrome in sub-Saharan Africa.

Authors:  Olusola O Olawoye; Louis R Pasquale; Robert Ritch
Journal:  Int Ophthalmol       Date:  2014-05-21       Impact factor: 2.031

5.  Solar exposure and residential geographic history in relation to exfoliation syndrome in the United States and Israel.

Authors:  Louis R Pasquale; Aliya Z Jiwani; Tzukit Zehavi-Dorin; Arow Majd; Douglas J Rhee; Teresa Chen; Angela Turalba; Lucy Shen; Stacey Brauner; Cynthia Grosskreutz; Matthew Gardiner; Sherleen Chen; Sheila Borboli-Gerogiannis; Scott H Greenstein; Kenneth Chang; Robert Ritch; Stephanie Loomis; Jae H Kang; Janey L Wiggs; Hani Levkovitch-Verbin
Journal:  JAMA Ophthalmol       Date:  2014-12       Impact factor: 7.389

6.  Exfoliation syndrome and occludable angles.

Authors:  R Ritch
Journal:  Trans Am Ophthalmol Soc       Date:  1994

7.  Point prevalence of pseudoexfoliation syndrome in patients scheduled for cataract surgery in eye camps in yemen.

Authors:  Mutahar Al-Shaer; Mahfouth Bamashmus; Abdulmoghni Al-Barrag
Journal:  Middle East Afr J Ophthalmol       Date:  2010-01

8.  Disruption of the blood-aqueous barrier and lens abnormalities in mice lacking lysyl oxidase-like 1 (LOXL1).

Authors:  Janey L Wiggs; Basil Pawlyk; Edward Connolly; Michael Adamian; Joan W Miller; Louis R Pasquale; Ramez I Haddadin; Cynthia L Grosskreutz; Douglas J Rhee; Tiansen Li
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-02-10       Impact factor: 4.799

9.  Review: The role of LOXL1 in exfoliation syndrome/glaucoma.

Authors:  Benjamin T Whigham; R Rand Allingham
Journal:  Saudi J Ophthalmol       Date:  2011-07-27

Review 10.  LOXL1 Polymorphisms: Genetic Biomarkers that Presage Environmental Determinants of Exfoliation Syndrome.

Authors:  Louis R Pasquale; Jae Hee Kang; BaoJian Fan; Hani Levkovitch-Verbin; Janey L Wiggs
Journal:  J Glaucoma       Date:  2018-07       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.